---
title: "Top 10 HK Stock Gainers (10.22)"
description: "XUANZHUBIO-B(02575) rose 31.87%, with a trading turnover 278.4 Million HKD, and a year-to-date rose 417.2%. CHALIECO(02068) rose 30.52%, with a trading turnover 542.4 Million HKD, and a year-to-date r"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/262188959.md"
published_at: "2025-10-22T08:30:41.000Z"
---

# Top 10 HK Stock Gainers (10.22)

> XUANZHUBIO-B(02575) rose 31.87%, with a trading turnover 278.4 Million HKD, and a year-to-date rose 417.2%. CHALIECO(02068) rose 30.52%, with a trading turnover 542.4 Million HKD, and a year-to-date rose 77.6%. C C LAND(01224) rose 25%, with a trading turnover 31.6 Million HKD, and a year-to-date rose 27.1%.

Hang Seng Index has fell 0.94%, with a year-to-date rose 28.5%; Hang Seng TECH Index has fell 1.41%, with a year-to-date rose 32.6%.

XUANZHUBIO-B(02575) rose 31.87%, with a trading turnover 278.4 Million HKD, and a year-to-date rose 417.2%.

CHALIECO(02068) rose 30.52%, with a trading turnover 542.4 Million HKD, and a year-to-date rose 77.6%.

C C LAND(01224) rose 25%, with a trading turnover 31.6 Million HKD, and a year-to-date rose 27.1%.

### Related Stocks

- [02575.HK - XUANZHUBIO-B](https://longbridge.com/en/quote/02575.HK.md)
- [02068.HK - CHALIECO](https://longbridge.com/en/quote/02068.HK.md)
- [01224.HK - C C LAND](https://longbridge.com/en/quote/01224.HK.md)
- [02617.HK - TRANSTHERA-B](https://longbridge.com/en/quote/02617.HK.md)
- [01115.HK - 5100 XIZANG](https://longbridge.com/en/quote/01115.HK.md)
- [01126.HK - DREAM INT'L](https://longbridge.com/en/quote/01126.HK.md)
- [00259.HK - YEEBO (INT'L H)](https://longbridge.com/en/quote/00259.HK.md)
- [02005.HK - SSY GROUP](https://longbridge.com/en/quote/02005.HK.md)
- [00931.HK - CHINA HK POWER](https://longbridge.com/en/quote/00931.HK.md)
- [01033.HK - SINOPEC SSC](https://longbridge.com/en/quote/01033.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 港股异动：轩竹生物-B 涨 12.98%，新总经理上任能否稳住市场信心？ | 轩竹生物-B 涨 12.98%；翰森制药涨 4.25%，成交额达到 13.83 亿港币；石药集团涨 2.37%，成交额达到 5.75 亿港币；中国生物制药涨 1.52%，成交额达到 1.68 亿港币；恒瑞医药涨 4.23%，市值达到 515 | [Link](https://longbridge.com/en/news/271726969.md) |
| 港股异动：轩竹生物-B 暴跌 15.34%，高管辞任引发市场担忧 | 轩竹生物-B 跌 15.34%；石药集团涨 3.89%，成交额达到 6.14 亿港币；中国生物制药涨 3.30%，成交额达到 3.12 亿港币；恒瑞医药涨 2.83%，成交额达到 1.78 亿港币；翰森制药涨 3.90%，市值达到 2292 | [Link](https://longbridge.com/en/news/271457426.md) |
| 港股异动：管理层变动引发市场信心，轩竹生物-B 股价飙升 15.34% | 轩竹生物-B 涨 15.34%；翰森制药涨 3.63%，成交额达到 14.52 亿港币；石药集团涨 2.14%，成交额达到 7.43 亿港币；中国生物制药涨 1.22%，成交额达到 2.84 亿港币；恒瑞医药涨 2.88%，市值达到 509 | [Link](https://longbridge.com/en/news/271733546.md) |
| 石四药集团在中国获得了两种产品的原料药批准 | 石四药集团在中国获得两款产品的原料药批准 | [Link](https://longbridge.com/en/news/275313672.md) |
| 石四药集团获得 NMPA 批准三甲氧基苯酚和盐酸多巴酚丁胺 | 石四药集团已获得中国国家药品监督管理局（NMPA）对三甲基酚甘油醚和盐酸多巴胺作为原料药注册的批准。三甲基酚甘油醚用于治疗与消化和妇科疾病相关的急性痉挛性疼痛，而盐酸多巴胺用于心力衰竭的治疗。该公告通过香港证券交易所的发行人信息服务发布 | [Link](https://longbridge.com/en/news/275301786.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.